1020 Locust Street
Jefferson Alumni Hall, Suite 336F
Philadelphia, PA 19107
(215) 503-6147
(215) 503-4235 fax
Jefferson Alumni Hall, Suite 336F
Philadelphia, PA 19107
(215) 503-6147
(215) 503-4235 fax
Most Recent Peer-reviewed Publications
- PI3K/AKT and mTOR/p70S6K1 signaling pathways in human cancer
- Oxygen-independent regulation of HIF-1: Novel involvement of PI3K/ AKT/mTOR pathway in cancer
- Roles of EGFR, PI3K, AKT, and mTOR in heavy metal-induced cancer
- MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers
- MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas
- Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis
- A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
- Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1
- Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability
- Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation
- MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF
- AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis
- Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells
- Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model
- Multifunctional role of Bcl-2 in malignant transformation and tumorigenesis of Cr(VI)-transformed lung cells
- Probabilistic suffix array: Efficient modeling and prediction of protein families
- MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1
- MiR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
- miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
- Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFκB-cMyc-p21 pathway